17,000 Shares SUNESIS PHARMACEUTICALS, INC. Series E Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2019 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2019 Company Industry Jurisdiction